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Purpose: A few nonrandomized studies have reported the natural history of carotid artery stenosis (CAS) contralateral to
carotid endarterectomy (CEA). This study analyzed this condition with data from two randomized prospective trials.
Methods: The contralateral carotid arteries in 534 patients from two randomized trials that compared CEA with primary
closure versus patching were followed up clinically and with duplex ultrasound scanning at 1 month and then every 6
months. CAS was classified as less than 50%, 50% to 79%, 80% to 99%, and occlusion. Late contralateral CEA was
performed to treat significant CAS. Progression was defined as progress to a higher category of stenosis. Kaplan-Meier life
table analysis was used to estimate freedom from progression of CAS. The correlation of risk factors and CAS progression
was also analyzed.
Results: Of 534 patients, 61 had initial contralateral CEA and 53 had contralateral occlusion. Overall, CAS progressed in
109 of 420 patients (26%) at mean follow-up of 41 months. Progression of CAS was noted in 5 of 162 patients (3%) with
baseline normal carotid arteries. CAS progressed in 56 of 157 patients (36%) with less than 50% stenosis versus 45 of 95
patients (47%) with 50% to 79% stenosis (P  .003). Median time to progression was 24 months for less than 50% CAS,
and 12 months for 50% to 79% CAS (P  .035). At 1, 2, 3, 4, and 5 years, freedom from disease progression in patients
with baseline CAS <50% was 95%, 78%, 69%, 61%, 48%, respectively, and in patients with 50% to 79% CAS was 75%, 61%,
51%, 43%, and 33%, respectively (P  .003). Freedom from progression in patients with baseline normal carotid arteries
at 1 through 5 years was 99%, 98%, 96%, 96%, and 94%, respectively. Late neurologic events referable to the CCA were
infrequent (28 of 420 [6.7%] in the entire series; 28 of 258 [10.9%] patients with contralateral CAS), and included 10
strokes (2.4%) and 18 transient ischemic attacks (4.3%). However, late contralateral CEA was performed in 62 patients
(62 of 420 [15%] in the entire series; 62 of 258 [24%] patients with contralateral CAS). Survival rates were 96%, 92%,
90%, 87%, and 82%, respectively, at 1 through 5 years.
Conclusions: Progression of CCA stenosis was noted in a significant number of patients with baseline contralateral CAS.
Serial clinical studies and duplex ultrasound scanning every 6 to 12 months in patients with 50% to 79% CAS, and every
12 to 24 months in patients with 50% or less CAS is adequate. (J Vasc Surg 2003;38:1154-61.)
The natural history of the progression of carotid artery
stenosis (CAS) is not well-defined; however, a few nonran-
domized studies have reported the natural history of CAS
contralateral to carotid endarterectomy (CEA).1-7 Reports
on the incidence of neurologic events in these studies
conflict.1-7 Several other studies have yielded mixed results
regarding the value of serial carotid artery duplex ultra-
sound (US) scanning in patients with asymptomatic
CAS.8-14
In view of these conflicting results, we designed this
study to analyze the natural history of CAS contralateral to
CEA, with data from two randomized prospective trials.
METHODS
Patient population. The contralateral carotid arteries
in 534 patients who participated in two randomized trials
comparing CEA with primary closure versus patching were
followed up clinically and with duplex US scanning at 1
month and every 6 months thereafter. Details of random-
ization in these two trials have been published.15,16 Data
for patients with occlusion of the contralateral carotid
artery at initial duplex US scanning or initial contralateral
CEA to treat symptomatic stenosis 50% or greater or
asymptomatic stenosis 80% or greater were excluded from
analysis. Late contralateral CEA was considered in patients
with symptomatic CAS 50% or greater or asymptomatic
stenosis 80% to 99%.
Follow-up duplex US scanning protocol. Carotid
color duplex US scanning was performed in all patients at
the initial visit (at initial CEA) with the HDI 3000 and
HDI 5000 systems (Advanced Technology Laboratory,
Bothwell, Wash), and was repeated at 30 days, 6 months,
and every 6 to 12 months thereafter (every 6 months in
patients with 50% or greater stenosis, and every 12 months
in patients with less than 50% stenosis). CAS was classified
as less than 50%, 50% to 79%, 80% to 99%, and total
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occlusion. The severity of stenosis was determined on the
basis of our previously described criteria.17
Clinical end points and definitions. Clinical end
points were transient ischemic attack (TIA) and stroke
appropriate to the hemisphere opposite the previous CEA.
TIA was defined as a focal hemispheric deficit that lasted
less than 24 hours. Attacks of amaurosis fugax were in-
cluded in this category. Stroke was defined as hemispheric
neurologic deficit that lasted more than 24 hours. Progres-
sion of CAS was defined as increase in internal carotid artery
stenosis to 50% or greater for carotid arteries with baseline
stenosis less than 50% or as increase to a higher category of
stenosis if the initial stenosis was 50% or greater (eg, 50%-
79% to 80%-99% or occlusion).
Statistical analysis. Statistical analysis was performed
with the 2 test and the Student t test. Kaplan-Meier life
table analysis was used to estimate freedom from progres-
sion of stenosis and survival rates. Incidence of CAS pro-
gression was analyzed in association with recorded risk
factors.
RESULTS
Of 534 patients, 61 patients underwent initial con-
tralateral CEA to treat symptomatic greater than 50% ste-
nosis or asymptomatic greater than 80% stenosis, and 53
patients had contralateral carotid artery occlusion. The
remaining 420 patients constitute the patient population of
this study. Demographic data and clinical characteristics of
these patients have been published.15,16
Mean number of carotid duplex US scanning proce-
dures in the entire series, excluding the first 30-day post-
operative examination, was 3 (range, 1-10; SD 1.9). Over-
all, disease progressed in 109 of 420 (26%) patients at mean
follow-up of 41 months (range, 1-116 months). CAS pro-
gression was noted in 5 of 162 patients (3%) with baseline
normal carotid arteries, 56 of 157 patients (36%) with less
than 50% stenosis (to 50%-79% in 52 patients and to
80% stenosis in 4 patients), and 45 of 95 patients (47%)
with 50% to 79% stenosis (Table I). Disease progressed in 3
of 6 patients (50%) with 80% or greater stenosis. These 6
patients were either too sick to undergo any intervention or
refused CEA. The rate of progression was statistically sig-
nificantly higher in patients with 50% to 79% stenosis
compared with patients with less than 50% stenosis (P 
.003). The rate of progression in patients with less than 50%
stenosis or 50% to 79% stenosis was also statistically signif-
icantly higher compared with patients with initial baseline
normal carotid artery (P  .0001). In addition, rate of
progression in patients with 50% to 79% stenosis was statis-
tically significantly higher compared with the whole group
(P  .001).
Sixty-one patients underwent initial CEA. Nine of
these patients had symptomatic 50% to 79% stenosis, and
52 patients had greater than 80% stenosis (Table I). Late
CEA was performed in another 62 patients with 80% or
greater asymptomatic stenosis or 50% to 79% symptomatic
stenosis (62 of 420 patients, 15% in whole series; 62 of 258
patients, 24% of patients with initial contralateral CAS). In
the entire series, 123 early and late CEAs of the contralat-
eral carotid artery were performed.
Median and mean time to CAS progression in all
groups is shown in Table II. Median time to CAS progres-
sion was 24 months in patients with less than 50% stenosis
and 12 months in patients with 50% to 79% stenosis (P 
.035).
Kaplan-Meier life table analysis showed that freedom
from progression of CAS at 1, 2, 3, 4, and 5 years in patients
with baseline less than 50% stenosis was 95%, 78%, 69%,
61%, and 48%, respectively, and for patients with 50% to
79% stenosis was 75%, 61%, 51%, 53%, and 33%, respec-
tively (P  .003). Freedom from progression in patients
with baseline normal carotid arteries was 99%, 98%, 96%,
96%, and 94% at 1, 2, 3, 4, and 5 years, respectively.
Freedom from progression of CAS was statistically signifi-
cantly higher in patients with normal carotid arteries com-
pared with patients with less than 50% stenosis and 50% to
79% stenosis (P  .0001). Life table analysis of freedom
from CAS progression for various categories of stenosis is
summarized in Tables III and IV, and Figs 1 and 2.
Overall, late neurologic events referable to the con-
tralateral carotid artery were relatively infrequent (28 of
420 patients in the entire series [6.7%]; 28 of 258 patients
with contralateral stenosis [10.9%]). These included 10
strokes (2.4%) and 18 TIAs (4.3%). Nine strokes were
Table I. Progression of contralateral carotid artery stenosis
Initial contralateral
carotid artery stenosis
No. of
arteries
Initial
contra-
lateral CEA
No. of patients
left for follow-
up
Arteries with
disease
progression
Symptoms: TIA
or stroke*
n %
A. Normal carotids 162 0 162 5 3 1 (1)
B. 50% stenosis 157 0 157 56 36 12 (4)
C. 50%-79% stenosis 104 9 95 45 47 11 (2)
D. 80%-99% stenosis 58 52 6 3 50 3 (3)
E. Occluded 53 0 0 0 0 0
F. Total 61 420 109 26
CEA, Carotid endarterectomy; TIA, transient ischemic attack.
P  .001, A vs B, A vs C; A vs F, B vs F, C vs F; P  .003, B vs C.
*Number of strokes in parentheses.
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associated with 50% or greater stenosis: in 4 patients initial
stenosis less than 50% progressed to 50% or greater; 2
patients had initial stenosis 50% to 79%; and 3 patients had
initial stenosis 80% or greater and refused CEA. One addi-
tional stroke occurred in a patient with an initial normal
carotid artery in which less than 50% stenosis developed
(Table I). Six additional non-carotid-artery stroke events
were noted in this series: two were thought to be cardiac
thromboembolic events; one was secondary to intracranial
hemorrhage; and three were of undetermined cause.
Kaplan-Meier survival rates were 96%, 92%, 90%, 87%,
and 82% at 1, 2, 3, 4, and 5 years, respectively (Fig 3).
Overall, there were 77 late deaths: 39 secondary to myo-
cardial infarction, 14 from malignancy, five from kidney
failure, four from congestive heart failure, three from pneu-
monia, three from stroke, two from multiple system failure,
one from respiratory failure, one from suicide, one from
trauma, and four from unknown cause.
Univariate analysis of various risk factors and progres-
sion of stenosis is summarized in Table V, Patients with
hypertension and hypercholesterolemia had a statistically
significantly higher incidence of CAS progression at univar-
iate analysis; however, these variables were not significant at
logistic regression analysis.
DISCUSSION
Several studies have followed up patients with mild to
moderate CAS with serial duplex US scanning and have
estimated the rate of progression of CAS. Reported overall
incidence of CAS progression ranges from 4% to 29%, and
estimated annual incidence of CAS progression ranges from
1.5% to 7%.11-13,18-20 The variability of this reporting can
be attributed to several factors, including the definition of
CAS progression and duration of follow-up. Some author-
ities define stenosis progression as any change in carotid
stenosis to a higher category.11,19,20 Others define progres-
sion of stenosis when it reaches 50% to 79%.12,18 Our study
analyzed the natural history of CAS contralateral to CEA
from two randomized prospective trials. Our findings were
somewhat similar to some of these previously reported
studies. Rate of progression varies according to baseline
CAS. At 1, 2, 3, 4, and 5 years, freedom from progression
in patients with baseline CAS less than 50% was 95%, 78%,
69%, 61%, and 48%, respectively, and in patients with 50%
to 79% CAS was 75%, 61%, 51%, 43%, and 43%, respec-
tively. To be noted, the categories of stenosis are not
equivalent between the various groups; that is, it may take
much more progression of atherosclerosis to change the
degree of stenosis from less than 50% to greater than 50%
Table II. Mean and median time to disease progression (mos)
Initial contralateral
carotid arteries
No. of
arteries
Number of
arteries with
progression
Median
(mo)
Mean
(mo) SE
A. Normal carotids 162 5 16.8 22.9 7.28
B. 50% stenosis 157 56 24.1 30.6 2.69
C. 50%-79% stenosis 95 45 12.0 19.4 2.95
D. 80%-99% stenosis 6 3 13.8 16.3 9.79
E. Total 109 19.8 25.7 1.95
P  .035, B vs C.
Table III. Life table analysis: Time to disease progression
in patients with baseline 50% carotid artery stenosis
Interval
(mo)
Number at risk
at start
Number
failed
Cumulative
progression-
free rate (%) SE (%)
Entry 157 0 100 0
6 147 3 98 1.1
12 131 5 94.6 1.9
18 105 11 86.3 2.9
24 86 9 78.4 3.7
30 65 6 73.4 4.1
36 58 3 68.9 4.4
42 50 2 66.3 4.6
48 41 4 60.6 5.0
54 35 2 57.6 5.2
60 27 6 47.5 5.7
66 19 2 43.5 5.9
72 16 1 41.1 6.0
78 13 1 38.4 6.2
84 9 1 35.4 6.4
Table IV. Life table analysis: Time to disease progression
in patients with 50% to 79% carotid artery stenosis
Interval
(Mos)
Number at risk
at start
Number
failed
Cumulative
progression-free
rate (%) SE (%)
Entry 95 0 100 0
6 82 10 89.1 3.3
12 66 13 74.7 4.6
18 56 4 70.1 4.8
24 42 7 60.8 5.3
30 28 3 55.7 5.7
36 17 2 51.2 6.0
42 12 0 51.2 6.0
48 10 2 42.7 7.5
54 10 0 42.7 7.5
60 7 2 33.2 8.3
66 7 0 33.2 8.3
72 6 0 33.2 8.3
78 5 0 33.2 8.3
84 3 2 19.9 8.8
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Fig 1. Kaplan-Meier life table analysis of progression-free rates for various degrees of carotid artery stenosis.
Fig 2. Kaplan-Meier life table analysis of progression-free rates in entire series.
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than it would take for 50% to 79% stenosis to progress to
greater than 80% stenosis. Therefore the term progression
as used in our studies and other studies may be somewhat
artificial.
Degree of CAS and progression. As noted in our
study, only 5 of 162 patients (3%) with a normal carotid
artery at baseline had progression to CAS. However, 56 of
157 patients (36%) with less than 50% CAS had progression
over mean follow-up of 41 months. A few studies have
reported the progression of mild CAS with mixed results.
Johnson et al19 reported disease progression in 25 of 138
patients with less than 50% CAS (peak systolic velocity
125 cm/s), for a cumulative progression of 21% at 7
years. Only 4% of these patients had stenosis greater than
80%, and in none of these patients did stenosis progress to
complete occlusion. It should be noted that less than 50%
stenosis in our study was defined as peak systolic velocity
less than 140 cm/s, which may in part explain the discrep-
ancy between the rate of progression in this study and our
study.
Shanik et al21 reported stenosis progression in 259
carotid arteries over 96 months, with mean follow-up of 48
months. Thirty-five of 96 arteries (36%) with mild stenosis
showed progression, 21 developed 50% to 79% stenosis, 12
progressed to greater than 80% stenosis, and two pro-
gressed to carotid occlusion. Only two of these patients had
stroke. Meanwhile, Nehler et al12 reported progression of
less than 60% stenosis in 263 patients (434 carotid arteries)
with mean follow-up of 18 months. Eighteen arteries (4%)
in 17 patients (6.5%) progressed without symptoms to
greater than 60% stenosis. However, they also noted that
arteries with initial peak systolic velocity greater than 175
cm/s were significantly more likely to progress to greater
than 60% stenosis compared with arteries with peak systolic
velocity less than 175 cm/s. Thirty-one percent of arteries
with initial peak systolic velocity greater than 175 cm/s
progressed, in comparison with 1.8% with peak systolic
velocity less than 175 cm/s. Ellis et al22 reported overall
progression of 3.4% in 1034 arteries with less than 50%
stenosis at mean follow-up of 20 months. Overall, these
reports indicate that CAS less than 50% is at relatively low
risk for progression to 50% or greater. However, many
patients with disease progression underwent CEA, elimi-
nating the possibility of further progression. Therefore,
whether these lesions would have advanced to preocclusive
or occlusive disease is unknown. It should also be noted
that the definition of less than 50% stenosis varies between
these reports.
Most studies concluded that patients with 50% to 79%
stenosis are more likely to have disease progression com-
pared with patients with less than 50% stenosis, and are
significantly more likely to have stenosis greater than 80%
or carotid occlusion.11,14,19-21 The reported overall annual
rate of disease progression with moderate stenosis (50% to
79%) varies between 3% and 11%. Forty-five of 95 (47%) of
our patients with 50% to 79% CAS demonstrated progres-
sion to 80% or greater over mean follow-up of 41 months.
Muluk et al14 projected an 11% annual incidence of CAS
Fig 3. Kaplan-Meier life table analysis of survival rates.
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progression, and risk correlated with initial CAS. Relative
risk for progression to greater than 50% stenosis, compared
with less than 50% stenosis, was 3.34 times, and the differ-
ence in risk for progression was statistically significant.
Shanik et al21 concluded that 21 of 104 arteries (25%) with
50% to 79% stenosis had disease progression to greater than
80% stenosis, and six progressed to carotid occlusion. John-
son et al19 concluded that 20 of 94 arteries (27%) with
initial 50% to 79% stenosis progressed to greater than 80%
within 7 years, and 20% progressed to complete occlusion.
Annual progression in their series was 3.7%, which was
significantly higher than for arteries with initial stenosis less
than 50%, of which only 4% progressed to greater than 80%
stenosis and none progressed to carotid occlusion. How-
ever, they also noted that in 19% of patients progression
involved the carotid artery with less initial stenosis.
Patients with 80% or greater CAS are at significant risk for
progression to carotid occlusion, and this risk has been esti-
mated to be as high as 35% at 24 months.23-25 It should be
noted that the true natural history of greater than 80% stenosis
is difficult to ascertain, because most, if not all, patients with
this degree of stenosis will undergo endarterectomy. In our
series, of 58 patients with initial contralateral CAS 80% to
99%, 52 underwent initial CEA and only 6 patients (risk for
surgery too high) were left to observation; in 3 of the 6 (50%)
stenosis progressed to complete occlusion.
Progression of CAS and neurologic events. Overall
late neurologic events referable to contralateral CAS in our
series were relatively infrequent (28 of 420 [6.7%] in the
whole series; 28 of 258 [10.9%] in patients with contralat-
eral stenosis). These included 10 strokes (2.4%) and 18
TIAs (4.3%). Nine strokes were associated with progression
to 50% or greater stenosis: four of these patients had initial
stenosis less than 50%, two had initial carotid stenosis 50%
to 79%, and three had initial stenosis 80% to 99% but
refused CEA. This number can be somewhat underesti-
mated, because it is our policy to operate on patients with
80% or greater stenosis before onset of neurologic events.
This indication for CEA will be better delineated after
publication of the European Asymptomatic Carotid Sur-
gery Trial. This low number of neurologic events may also
be attributed to what some believe to be a protective effect
of contralateral CEA.
Muluk et al14 reported that the initial risk for progres-
sion of CAS was 9.3%, increasing steadily over time. Pa-
tients with progression of stenosis were at increased risk for
stroke or TIA, compared with patients without progression
(21% vs 11%), which was statistically significant.14 Simi-
larly, Mansour et al11 reported the natural history of 142
patients with 50% to 89% asymptomatic CAS who under-
went serial color duplex US scanning with mean follow-up
of 44 months. Of the 21 patients with disease progression
to greater than 80%, symptoms developed in seven patients
(33%), three with ipsilateral TIA and four with stroke. By
contrast, symptoms developed in only 4% of patients (5 of
118) with stable disease.
Johnson et al16 reported that, in patients with less than
50% stenosis, 2 of 25 patients (8%) with disease progression
to greater than 80% stenosis had stroke, in contrast to 3 of
113 patients (2%) with less than 50% stenosis and no
Table V. Univariate analysis of risk factors and progression of carotid artery stenosis
Risk factors
No progression (%) Progression (%)
Pn % n %
Gender
Male 157 78.5 43 21.5 .0503
Female 155 70.5 65 29.5
Hypertension
Yes 140 67.3 68 32.7
No 172 81.1 40 18.9 .001
Diabetes mellitus
Yes 84 77 25 23
No 228 73.3 83 26.7 .396
Coronary artery
disease
Yes 168 73.4 61 26.6
No 144 75.4 47 24.6 .580
Smoking
Yes 161 74.2 56 25.8
No 150 73.9 53 26.1 .923
Age
Mean 68.9 68.1 .058
Range 35-90 49-86
Cholesterol
Mean 206 220 .0048
Range 72-491 116-339
Triglycerides
Mean 222 233 .278
Range 43-1026 48-681
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progression. Six of 20 patients with 50% to 79% stenosis
and progression to greater than 80% stenosis had stroke,
compared with 1 of 74 patients with similar stenosis and no
disease progression. They also reported that the eventual
stroke rate for patients with disease progression may have
been higher, but 5 of 138 patients with less than 50% initial
stenosis and 22 of 94 patients (24%) with initial 50% to 79%
stenosis underwent CEA because of stenosis progression.
Rockman et al20 reported 496 asymptomatic carotid
arteries with mean follow-up of 38 months. Forty-eight
arteries (17%) showed disease progression, which was asso-
ciated with a significantly higher risk for stroke compared
with arteries that remained stable (10.4% vs 2.1%). They
also indicated that arteries with stable disease were more
likely to remain asymptomatic compared with arteries with
progression (96% vs 63%).
Roederer et al3 reported the outcome of 134 patients
followed up with serial duplex US scanning after unilateral
CEA. They concluded that there was a strong relationship
between development of neurologic events and 80% to 99%
stenosis. Risk for development of a neurologic event was
50% in patients with 80% to 99% stenosis, compared with
7% in patients with less than 80% stenosis.
Risk factors and CAS progression. Several studies
have reported the correlation of CAS progression and risk
factors including age, gender, diabetes mellitus, smoking,
coronary artery disease, hypercholesterolemia, hyperten-
sion, associated peripheral vascular disease, neurologic
symptoms at presentation, homogeneity or echolucency of
plaque, and various peak systolic velocities of the internal
carotid artery.11,12,14,26 In accordance with these studies,
no statistically significant correlation was found between
these factors and disease progression in our series. Several
reports have identified a relationship between continued
smoking and increased risk for disease progression3,27,28;
others have found no correlation.9,20,23
Systolic blood pressure has been frequently correlated
with disease progression. Muluk et al14 reported that pa-
tients with systolic blood pressure greater than 160 mm Hg
were 1.37 times more likely to have progression compared
with patients with systolic blood pressure less than 160 mm
Hg. The degree of initial internal carotid artery stenosis is
associated with risk for progression. Patients with greater
than 50% stenosis initially had a higher incidence of pro-
gression compared with patients with less than 50% CAS.
Nehler et al12 concluded that mean initial peak systolic veloc-
ity of the internal carotid artery of 180 cm/s was associated
with progression, in contrast to 104 cm/s in patients with
stable disease. Thirty-one percent of patients with asymptom-
atic internal carotid artery stenosis with initial peak systolic
velocity greater than 175 cm/s had disease progression, in
contrast to 1.8% of patients with internal carotid arteries with
peak systolic velocity less than 175 cm/s.
CONCLUSIONS
Progression of contralateral CAS was noted in a signifi-
cant number of patients with baseline contralateral CAS. For
patients with less than 50% CAS, the chance for progression to
50% or greater stenosis, which may lead to an ischemic event,
is relatively low; however, this progression can be somewhat
substantial over the long term, as noted in our series. Carotid
duplex US scanning every 12 to 24 months in patients with
less than 50% stenosis is perhaps adequate. For patients with
50% to 79% stenosis, progression of disease becomes statisti-
cally significantly higher, and may be associated with neuro-
logic events. Therefore duplex US scanning every 6 to 12
months in these patients may be beneficial.
We thank Christine A. Welch, MS, CAMC Outcomes
Research, Charleston, W Va, for assistance with statistical
analyses.
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DISCUSSION
Dr Patrick J. Lamparello (New York, NY). NYU is a center
with a large experience in carotid surgery. We have been very inter-
ested in the topic presented today, namely follow-up with duplex
scanning of carotid artery stenosis contralateral to carotid artery end-
arterectomy. The paper presented today yields practical information
and advice on how to follow patients after carotid endarterectomy.
We have long been concerned about the frequency of follow-up for
our patients after carotid surgery. Should patients have follow-up
duplex scans at yearly intervals or can the time between scanning be
increased for patients with mild or moderate stenosis opposite carotid
artery endarterectomy. The data presented today help answer some of
these questions. We are all concerned about the same goal, namely to
prevent our patients from having strokes.
We’re also indebted to Dr AbuRahma for this large series of
patients with excellent data. I have two questions for Dr Abu-
Rahma. May I first say that I enjoyed reading your excellent paper.
I am somewhat concerned about the incidence of late neurologic
events of 6.7%. This seems higher than what it ought to be in a
group of patients who are followed closely and probably have had
other risk factor reduction for stroke such as cessation of smoking,
maintenance of blood pressure control, and anti-platelet medica-
tion. Can you shed any light on this higher incidence of neurologic
events than what we would expect?
My second question relates to the risk factors for progression
of carotid artery stenosis and neurologic events. In your paper you
note that female sex, hypercholesterolemia, and hypertension were
statistically significant for progression of carotid artery stenosis. I
would ask if these risk factors and others that you looked at would
stand the test of a multivariate analysis.
Dr Ali F. AbuRahma. In regard to the late neurologic events,
I agree with you, and the way you define it depends on the clinician
looking at the data. A surgeon would probably consider it relatively
high, but a neurologist may consider it relatively low. Can I justify
doing all of the follow-up to prevent an 11% neurologic event,
particularly the stroke portion of it? My answer is, perhaps, yes. Keep
in mind that all of our patients may not have adhered to our recom-
mendations regarding controlling risk factors, ie, abstinence from
smoking or hypertension. In regard to risk factors, the only risk factors
that we felt were associated with a significant increase of progression in
our study were hypertension and hypercholesterolemia.
Dr Peter J. Pappas (Newark, NY). I’d like to thank you for
bringing this data to our attention. Sitting and listening to your
presentation, I was trying to decide whether the cup was half full or
half empty. You indicated that the majority of stenoses progressed,
but you neglected to indicate the final degree of stenosis. In other
words, a patient who has a 50% stenosis progresses to a 50%
stenosis and remains symptom-free is not clinically relevant. Do
you treat that patient?
I’m assuming that the majority of these patients had asymp-
tomatic disease. And your 10.9% stroke rate essentially confirmed
the ACAS data of the medical arm. So I’m not quite sure what to
do with this information. About half of our patients will progress in
the worst-case scenario. They may progress to a stenosis that I’m
not going to do anything about, and I don’t know if that justifies
performing serial duplex exams on them.
Dr AbuRahma. That’s a good question. Again, back to half
full/half empty, that’s again whether you are an internal medicine
physician or a surgeon. If you’re looking at people on whom to
operate at 80% and above, then I think half full. If you’re looking
at people on whom you’re not going to operate unless they have
symptomatic lesion, that’s probably half empty. So what I’m trying
to tell you is, I don’t blame you, because you don’t have the paper
in front of you, but in our paper we actually not only indicate how
many of these progressed, but if they progressed, that they pro-
gressed to 50%, they progressed to 80%. However, the progression
in our series was, in my judgment, associated with relatively infre-
quent neurologic events, if you are looking at stroke victims only
and not transient ischemic attacks.
Dr Pappas. If I can just follow up with one other question:
I’m really intrigued by this paper because of the previous article
that you published in which you looked at plaque morphology. In
the subset of patients who progressed, did you do any of your
plaque morphology analyses on those patients, and do you think
that plaque morphology is more important than progression?
Dr AbuRahma. That’s an excellent question. In regard to
which patients progressed and to what degree, these data are
available in the paper: whether 50% progressed to 50% and so
forth. It’s true that most of the patients who progressed were
symptom-free, with roughly 11% associated with neurologic events
and around 6% associated with ipsilateral strokes. In regard to
managing these patients, if the patients were50 percent and had
symptoms, they generally underwent surgery. However, in symp-
tom-free patients, surgery was considered if progression reached
80% and above, which is similar to what most authorities would do,
particularly in good-risk patients. Keep in mind, all of the patients
who were enrolled in this prospective trial had asymptomatic
stenoses that were not initially operated on.
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